which I frequently saw during my years as a naval ENT consultant. Now that I am working as a civilian ENT consultant in the British Military Hospital, Berlin, I have seen many cases of radiologically normal sinuses in patients with maxillary and frontal headaches who have been rendered symptom-free by bilateral intranasal antrostomies. (In some cases, symptoms have returned when the antrostomy has closed!)
The British population in Berlin seem unusually prone to nasal congestion and mild vasomotor rhinitis which, I am sure, is related to the enormous number of linden trees (lime) and silver birch. In the winter time, very powerful central heating in living areas, without adequate humidification, plays a significant part in the congested nose syndrome. P W HEAD British Military Hospital, Berlin Sir, Miss Lund's stimulating article on the design and function of intranasal antrostomies (November 1986 JRSM, p 646) unfortunately omitted to mention anything about the nasal symptoms of antral mucosal dysfunction in both retrospective and prospective groups in relation to the subsequent size of their intranasal antrostomies. Although not purely relevant to her dimensional study, this information would help to put these data into some clinical perspective. I would also be interested to know what proportion of her antrostomal closures were due to mucosa or bone.
The antrostomy allows improved oxygenation of the antral mucosa, bringing about at least three effects: recovery of ciliary function, breaking the disulphide bonds of tenacious mucus and improvement in host myeloperoxidase function. If Miss Lund is worried about the possible relationship of antrostomy size with viscosity, this may imply that the effect of the infection in these cases was too advanced for antrostomy ventilation to be reversed in the first place; this may, therefore, not be the fault of the antrostomy itself. On this basis, her acknowledgment that a short history of infection would be reversed by antrostomy more effectively is mutually exclusive with her concern for viscosity and antrostomy size. N J KAY Consultant Otolaryngologist Stockport Infirmary, Cheshire
*Miss Lund replies below:
Sir, I would endorse Mr Kay's comments regarding the importance ofmucociliary function to the success of the inferior meatal antrostomy. As yet, no infallible method exists to define those patients with irreversibly damaged maxillary sinus mucosa, in whom an antrostomy of any size would probably be clinically ineffective. As we are not in a position to know whether increased mucous viscosity implies advanced disease, I do not think the consideration that a short history of infection is the most suitable indication for this operation in any way excludes a concern regarding viscosity or size.
A careful assessment of subjective clinical improvement in patients who had undergone intranasal antrostomies as part of the prospective study was conducted and correlated with the size and natural history of the antrostomy. Assessments were conducted at regular intervals postoperatively and in depth at one year. The majority of patients experienced an improvement in nasal obstruction, postnasal drip, rhinorrhoea, facial pain and headache (75%. 34%, 60%, 49% and 47% respectively). The improvement in postnasal drip was less dramatic than for other symptoms, with 34% claiming improvement, 32% no change and 26% a worsening of symptoms. This reflects the drainage of sinus secretions via the antrostomy, as a consequence of which patients can expect an improvement in certain symptoms at the expense of an increase in 'catarrh' and may complain bitterly at this turn of events. Sense of smell was improved in 31% but remained unaltered in 49%.
In 9 patients whose antrostomies underwent rapid closure associated with infection, an exacerbation ofsymptoms was experienced at the time of the infection. Otherwise change in size of the antrostomy, particularly gradual closure, was not indicated clinically in the majority of patients, so the critical functional size of the antrostomy remains to be determined. However, in 7 patients exacerbation of symptoms did occur in the presence of significant closure which necessitated revision procedures. It is also of interest that patients may be clinically asymptomatic despite large antrostomies from which pus or polypoid mucosa are extruding,
The closure in all cases was fibrous.
V J LUND

Lecturer in Rhinology Institute of Laryngology and Otology, London
Radiation-induced bowel damage following treatment of uterine carcinoma Sir, The report by Allen-Marsh and colleagues on radiation-induced damage to the bowel following treatment of uterine carcinoma (July 1986 JRSM, p 387) reflects our experience in recent years, except that surgery for cervical as opposed to endometrial cancer was an adverse feature. The reasons for this are under study.
The report, however, is a little unclear on the categorization of the radiation-induced bowel injuries. It would be helpful to have this in more detail, together with treatment outcome. This difficult topic needs consideration on a cost/benefit basis. Radiation complication can always be minimalized by reduction of therapeutic efficacy.
The report covers a period of technical change which tends to blur the value of conclusions. In our local practice, my colleagues' introduction of posterior lead shielding and angulation of the central source away from the relatively fixed rectosigmoid junction has appeared beneficial.
True rectovaginal fistula as an entity on its own is relatively uncommon, and may represent an untoward event during therapy, such as a shift of an intrauterine source. This can certainly OCcurwith a rigid applicator and spacers attached to a perineal bar, as suggested by the authors.
From time to time the apex of a redundant sigmoid colon becomes adherent to the back of the cervix in the pouch of Douglas, where it is at greater risk than the rectum. Colovaginal fistula is often confused with high rectovaginal fistula. If such fistulae are managed only with colostomy, the distinction is not important, but stoma-sparing colpocleisis is an option often overlooked and requires an accurate diagnosis of fistula site. Transvaginal closure with vaginal fistulae ofirradiation origin using colpoclei-sis with a pedicle graft is usually feasible but is a very specialized surgical technique I. It does provide an alternative to a stoma, and sometimes a double stoma, always an added burden to a patient who already suffered a great deal. Colpocleisis should always be considered even if local tumour activity cannot be excluded. Reference to another specialist for diversion is not necessarily in the patient's best interest. In his 1985J Y Simpson Oration (to be published), Lawson, with an unrivalled experience, made a similar observation on incidence and commented on delays of the order of 20 years in the production of fistulae. Longer follow-up will be necessary to quantitate the problem. C *Mr Allen-Mersh and colleagues reply below:
Sir, We were interested to read that our experience of radiation injury following treatment of uterine carcinoma is similar to that in other centres. It may be misleading to relate, as Hudson and others have done, the incidence of radiation injury to therapeutic success. The first objective is to cure the patient, but it does not follow that cure is more likely if there is a higher incidence of radiation-induced injury. There
Book reviews
ManualofHaematology AS J Baughan et al. pp 274 £8.95 ISBN 0-443-02564-9 Edinburgh: Churchill Livingstone 1986 This book, one of a series, has been designed for junior doctors looking after haematological patients. It is written in a spare style, mostly as lists, enabling the reader rapidly to review the causes, further investigations and management of various problems. Thus most subjects are not discussed in depth, and references are given as a guide to further reading. There is adequate coverage of most common and not-so-common haematological disorders (although paroxysmal nocturnal haemoglobinuria seems rather neglected). The chapter on cytotoxic chemotherapy is excellent, and that on terminal care in haematological malignancy should be required reading for all junior doctors, and many haematologists as well. The chapter on myelodysplastic syndrome is somewhat muddled, seeming to use an odd classification based on the currently used FAB classification and older terminology now largely superseded. This does little to clarify what is a difficult subject. The authors state that they 'have attempted to express a consensus opinion on the more controversial aspects of clinical management', and for the was no significant change in the survival of our patients during the 20·year period which we reviewed. This important relationship between survival and radiation-induced injury could be examined in more detail if, as we suggested, there was a central national register of therapeutic radiationinduced injury.
It is true that the period which we analysed has seen a number of changes in technique. We did examine whether the increase in injury could be attributed to anyone factor, for example, the introduction of the Curietron, but such a simple relationship was not found. We do not use spacers attached to the perineal bar. Details of the pattern of injury and management are being published elsewhere.', In summary, the majority of cases of radiationinduced proctitis could be managed conservatively and the operation of choice for the radiation-injured rectum appeared to be rectal excision with transanal sleeve coloanal anastomosis. We have no experience of colpocleisis, as colovaginal fistula did not occur in our series. T G ALLEN·MERSH 
